Jonathan K.C. Knowles is a global opinion leader in personalized medicine. Former Head of Group Research and Member of the Executive Committee at Roche up to 2009. He was the chairman of the Corporate Governance Committee and a member of the Board at Genentech for the last 12 years. Jonathan Knowles was recently appointed Professor of Translational Medicine at EPFL in Switzerland, holds a Distinguished Professorship in Personalized Health Care at FIMM (Finnish Institute for Molecular Medicine) From the beginning of 2010, Dr. Knowles joined the Board of Caris Life Sciences, an international cutting edge molecular diagnostics company based in Irving, Texas. From May 2010 Dr. Knowles also assumes the role of Caris’ Chief Scientific Officer.

“Personalized medicine can impact patient care today.”